At the convergence of geroscience venture capital, private equity roll-ups, and ultra-luxury urban development lies Age-in-Place Longevity Real Estate. By embedding non-invasive diagnostic arrays, adaptive universal design, and invisible healthspan tech directly into private fee-simple units—where average resident retention stretches to 12 to 18 years—these developments de-risk tenant turnover to near-zero churn, boost net operating income by 28% to 42% through high-margin he